The diagnostic value of neuropathy symptom and change score, neuropathy impairment score and Michigan neuropathy screening instrument for diabetic peripheral neuropathy

European Neurology

Volumn 74, Issue 5-6, 2015, Pages 323-327

  Xiong, Qian ^a   Lu, Bing ^b   Ye, Hongying ^b   Wu, Xia ^a   Zhang, Tiansong ^a   Li, Yiming ^a  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Diabetes mellitus; Diabetic peripheral neuropathy; Michigan neuropathy screening instrument; Neuropathy impairment score; Neuropathy symptom and change

Indexed keywords

AGED; ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; DIABETIC NEUROPATHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; ELECTROMYOGRAPHY; FEMALE; GOLD STANDARD; HUMAN; MAJOR CLINICAL STUDY; MALE; MICHIGAN NEUROPATHY SCREENING INSTRUMENT; NERVE CONDUCTION VELOCITY TEST; NEUROLOGIC DISEASE ASSESSMENT; NEUROPATHY IMPAIRMENT SCORE; NEUROPATHY SYMPTOM AND CHANGE SCORE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTIVE VALUE; PREVALENCE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; MASS SCREENING; MICHIGAN; MIDDLE AGED; NEUROLOGIC EXAMINATION; PSYCHOMETRY; STATISTICS AND NUMERICAL DATA; VALIDATION STUDY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; ELECTROMYOGRAPHY; FEMALE; HUMANS; MALE; MASS SCREENING; MICHIGAN; MIDDLE AGED; NEUROLOGIC EXAMINATION; PSYCHOMETRICS;

EID: 84950150777     PISSN: 00143022     EISSN: 14219913     Source Type: Journal    
DOI: 10.1159/000441449     Document Type: Article

References (26)

1. Vinik A, Mitchell B, Leichter S, Wagner A, O'brian J, Georges L. Epidemiology of the complications of diabetes; in Leslie RDG, Robbins DC (eds): Diabetes: Clinical Science in Practice. Cambridge: Cambridge University Press, 1995, pp 221-287
2. Yang Z, Chen R, Zhang Y, Huang Y, Hong T, Sun F, Ji L, Zhan S. Scoring Systems to Screen for Diabetic Peripheral Neuropathy. The Cochrane Library, 2014
3. Boulton AJ, Vinik AI, Arezzo JC, Bril V, Feldman EL, Freeman R, Malik RA, Maser RE, Sosenko JM, Ziegler D; American Diabetes Association: Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care 2005; 28: 956-962
4. Miralles-Garcia JM, De Pablos-Velasco P, Cabrerizo L, Perez M, Lopez-Gomez V; Sociedad Espanola de Endocrinologia y Nutricion: Prevalence of distal diabetic polyneuropathy using quantitative sensory methods in a population with diabetes of more than 10 years' disease duration. Endocrinol Nutr 2010; 57: 414-420
5. Perkins B, Bril V. Electrophysiologic testing in diabetic neuropathy. Handb Clin Neurol 2014; 126: 235-248
6. Nasseri K, Strijers R, Dekhuijzen LS, Buster M, Bertelsmann FW. Reproducibility of different methods for diagnosing and monitoring diabetic neuropathy. Electromyogr Clin Neurophysiol 1998; 38: 295-299
7. England J, Gronseth G, Franklin G, Miller R, Asbury A, Carter G, Cohen J, Fisher M, Howard J, and Kinsella L. Distal symmetric polyneuropathy: a definition for clinical research: report of the American Academy of Neurology, the American Association of Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. Neurology 2005; 64: 199-207
8. Dyck PJ. Detection, characterization, and staging of polyneuropathy: assessed in diabetics. Muscle Nerve 1988; 11: 21-32
9. Dyck P. Evaluative procedures to detect, characterize, and assess the severity of diabetic neuropathy. Diabet Med 1991; 8: S48-S51
10. Feldman EL, Stevens MJ, Thomas PK, Brown MB, Canal N, Greene DA. A practical twostep quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care 1994; 17: 1281-1289
11. Perkins BA, Olaleye D, Zinman B, Bril V. Simple screening tests for peripheral neuropathy in the diabetes clinic. Diabetes Care 2001; 24: 250-256
12. Jayaprakash P, Bhansali A, Bhansali S, Dutta P, Anantharaman R, Shanmugasundar G, Ravikiran M. Validation of bedside methods in evaluation of diabetic peripheral neuropathy. Indian J Med Res 2011; 133: 645-649
13. Holiner I, Haslinger V, Lutschg J, Muller G, Barbarini DS, Fussenegger J, Zanier U, Saely CH, Drexel H, Simma B. Validity of the neurological examination in diagnosing diabetic peripheral neuropathy. Pediatr Neurol 2013; 49: 171-177
14. Moghtaderi A, Bakhshipour A, Rashidi H. Validation of Michigan neuropathy screening instrument for diabetic peripheral neuropathy. Clin Neurol Neurosurg 2006; 108: 477-481
15. American Diabetes Association: Standards of medical care in diabetes -2010. Diabetes Care 2010; 33: S11-S61
16. Young MJ, Boulton AJ, Macleod AF, Williams DR, Sonksen PH. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia 1993; 36: 150-154
17. Abbott CA, Carrington AL, Ashe H, Bath S, Every LC, Griffiths J, Hann AW, Hussein A, Jackson N, Johnson KE, Ryder CH, Torkington R, Van Ross ER, Whalley AM, Widdows P, Williamson S, Boulton AJ; North-West Diabetes Foot Care Study: The North-West Diabetes Foot Care Study: incidence of, and risk factors for, new diabetic foot ulceration in a community-based patient cohort. Diabet Med 2002; 19: 377-384
18. Moreira RO, Castro AP, Papelbaum M, Appolinario JC, Ellinger VC, Coutinho WF, Zagury L: [Translation into Portuguese and assessment of the reliability of a scale for the diagnosis of diabetic distal polyneuropathy]. Arq Bras Endocrinol Metabol 2005; 49: 944-950
19. Weintrob N, Amitay I, Lilos P, Shalitin S, Lazar L, Josefsberg Z. Bedside neuropathy disability score compared to quantitative sensory testing for measurement of diabetic neuropathy in children, adolescents, and young adults with type 1 diabetes. J Diabetes Complications 2007; 21: 13-19
20. Fornwalt BK, Sprague WW, Bedell P, Suever JD, Gerritse B, Merlino JD, Fyfe DA, Leon AR, Oshinski JN. Agreement is poor among current criteria used to define response to cardiac resynchronization therapy. Circulation 2010; 121: 1985-1991
21. Boulton AJ. Management of diabetic peripheral neuropathy. Clin Diabetes 2005; 23: 9-15
22. Smith AG, Singleton JR. Obesity and hyperlipidemia are risk factors for early diabetic neuropathy. J Diabetes Complications 2013; 27: 436-442
23. Xu F, Zhao LH, Su JB, Chen T, Wang XQ, Chen JF, Wu G, Jin Y, Wang XH. The relationship between glycemic variability and diabetic peripheral neuropathy in type 2 diabetes with well-controlled HbA1c. Diabetol Metab Syndr 2014; 6: 139
24. Cheliout-Heraut F, Zrek N, Khemliche H, Varnet O, Seret-Begue D, Martinez M, Nizou R, Bour F. Exploration of small fibers for testing diabetic neuropathies. Joint Bone Spine 2005; 72: 412-415
25. Bax G, Fagherazzi C, Piarulli F, Nicolucci A, and Fedele D. Reproducibility of Michigan Neuropathy Screening Instrument (MNSI). A comparison with tests using the vibratory and thermal perception thresholds. Diabetes Care 1996; 19: 904-905
26. Ewing DJ, Clarke BF. Diagnosis and management of diabetic autonomic neuropathy. Br Med J (Clin Res Ed) 1982; 285: 916-918